Small lipid core burden index in patients with stable angina pectoris is also associated with microvascular dysfunction: Insights from intracoronary electrocardiogram Takao SatoSho YuasaYoshifusa Aizawa OriginalPaper 02 February 2021 Pages: 1 - 8
Edoxaban, a direct oral factor Xa inhibitor, ameliorates coagulation, microvascular thrombus formation, and acute liver injury in a lipopolysaccharide-induced coagulopathy model in rats Yoshiyuki MorishimaTomoko ShibutaniYuko Honda OriginalPaper Open access 03 February 2021 Pages: 9 - 17
Major bleeding complications in critically ill patients with COVID-19 pneumonia Anne GodierDarless ClausseSophie Rym Hamada BriefCommunication 01 March 2021 Pages: 18 - 21
Extended duration venous thromboembolism prophylaxis with betrixaban for patients re-admitted with venous thromboembolism Monica FahmyKatelyn W. SylvesterSamuel Z. Goldhaber OriginalPaper 09 April 2021 Pages: 22 - 29
Procoagulant microparticles are associated with arterial disease in patients with systemic lupus erythematosus Miguel Angel Plasín-RodríguezPatricia PatricioDolors Tàssies OriginalPaper 03 October 2020 Pages: 30 - 41
Serotonin: a platelet hormone modulating cardiovascular disease Marina RiederNadine GauchelDaniel Duerschmied ReviewPaper Open access 05 November 2020 Pages: 42 - 47
Extracellular matrix collagen biomarkers levels in patients with chronic thromboembolic pulmonary hypertension Wenyi PangZhu ZhangChen Wang OriginalPaper 11 November 2020 Pages: 48 - 58
Aqueous extract of Whitmania pigra Whitman ameliorates ferric chloride-induced venous thrombosis in rats via antioxidation Peng LiBingqing LinBaoqin Lin OriginalPaper 17 November 2020 Pages: 59 - 68
Occurrence of pulmonary embolism related to COVID-19 Marie Hauguel-MoreauMostafa El HajjamNicolas Mansencal OriginalPaper 06 October 2020 Pages: 69 - 75
Combining lung ultrasound and Wells score for diagnosing pulmonary embolism in critically ill COVID-19 patients Viviane ZotzmannCorinna N. LangDawid L. Staudacher OriginalPaper Open access 03 November 2020 Pages: 76 - 84
Lupus anticoagulant and mortality in patients hospitalized for COVID-19 Carmine GazzarusoGiuseppe MarianiPietro Gallotti OriginalPaper 07 November 2020 Pages: 85 - 91
Increased interest in acute pulmonary embolism in Italy during the COVID-19 pandemic: a google trends-based analysis Loris RonconMarco ZuinStavros V Konstantinides Letter to the Editor 11 November 2020 Pages: 92 - 94
Clinical features of patients with acute coronary syndrome during the COVID-19 pandemic Kensuke MatsushitaSebastien HessOlivier Morel OriginalPaper 16 November 2020 Pages: 95 - 104
Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox? Franco RubertoAntonio ChistoliniPoliclinico Umberto I COVID-19 Group Report 02 January 2021 Pages: 105 - 110
SARS-CoV-2 infection and thrombotic complications: a narrative review Iraklis C. MoschonasAlexandros D. Tselepis ReviewPaper 15 January 2021 Pages: 111 - 123
Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis Chia Siang KowSyed Shahzad Hasan Letter to the Editor 04 April 2021 Pages: 124 - 129
Ultrasound-assisted catheter-directed thrombolysis versus systemic anticoagulation alone for submassive pulmonary embolism Theresa M. KlineAnne M. RodinoPrashanth Iyer OriginalPaper 29 September 2020 Pages: 130 - 137
Analysis of the quality of reporting of randomized controlled trials in anticoagulant versus antiplatelet medication for venous thromboembolism prophylaxis as governed by the CONSORT statement Eirini BenekiChristos VrysisChrysoula Doxani ReviewPaper 17 October 2020 Pages: 138 - 147
Mitochondria-DNA copy-number and incident venous thromboembolism among middle-aged women: a population-based cohort study Peter NymbergAshfaque A. MemonBengt Zöller OriginalPaper Open access 15 April 2021 Pages: 148 - 157
Reasons for new patient warfarin referrals to an anticoagulant management service in 2019: a single institution experience Katelyn W. SylvesterCaroline WagnerJean M. Connors Report 21 October 2020 Pages: 158 - 160
Evaluation of characteristics and dosing regimens in patients with new or recurrent thrombosis on apixaban and rivaroxaban Diane DreuceanSteffany N. NguyenMelanie C. Ruegger OriginalPaper 24 October 2020 Pages: 161 - 169
Elderly people are inherently sensitive to the pharmacological activity of rivaroxaban: implications for DOAC prescribing Emmanouela KampourakiSalah AbohelaikaFarhad Kamali OriginalPaper Open access 01 November 2020 Pages: 170 - 178
Outpatient management of patients presenting with venous thromboembolism: Retrospective cohort study at 11 community hospitals Rasha KhatibKara NittiWilliam Rhoades OriginalPaper Open access 07 November 2020 Pages: 179 - 188
Acute pulmonary embolism following recent hospitalization or surgery Colby ShanafeltRahul AggarwalBrett J. Carroll OriginalPaper 06 November 2020 Pages: 189 - 199
Working smarter, not harder: evaluating a population health approach to anticoagulation therapy management Connor RossierPatrick SpoutzMark E. Patterson OriginalPaper 22 November 2020 Pages: 200 - 208
Assessment of provider practices regarding venous thromboembolism management and prevention in pediatric acute leukemia patients Melanie DegliuominiVictoria CooleyNicole Kucine BriefCommunication 24 January 2021 Pages: 209 - 213
Clinical and sociodemographic factors associated with anticoagulant use for cancer associated venous thromboembolism Jordan K. SchaeferMengbing LiSuman L. Sood OriginalPaper 05 February 2021 Pages: 214 - 223
Plasma levels of extracellular vesicles and the risk of post-operative pulmonary embolism in patients with primary brain tumors: a prospective study Serena M. PassamontiAndrea ArtoniIda Martinelli OriginalPaper 10 April 2021 Pages: 224 - 231
Need for anticoagulation and use of direct oral anticoagulants in lung transplant recipients Christina C. KaoTai WangAmit D. Parulekar OriginalPaper 04 March 2021 Pages: 232 - 238
Management of warfarin-associated intracerebral hemorrhage before and after implementation of an order set and prospective pharmacist order verification Beth E. VarnesVinodkumar SinghCasey C. May OriginalPaper 04 March 2021 Pages: 239 - 247
Cardiac pathophysiology in sickle cell disease Oluwabukola Temitope GbotoshoMichael TaylorPunam Malik ReviewPaper 07 March 2021 Pages: 248 - 259
Clinical outcomes of very elderly patients treated with ultrasound-assisted catheter-directed thrombolysis for pulmonary embolism: a systematic review Mauricio Castillo-PerezCarlos Jerjes-SánchezMauricio Vazquez-Guajardo OriginalPaper 04 March 2021 Pages: 260 - 271
Clinical validation of AggreGuide A-100 ADP, a novel assay for assessing the antiplatelet effect of oral P2Y12 antagonists Paul A. GurbelUdaya S. TantryPhilip C. Speros OriginalPaper 18 June 2021 Pages: 272 - 280
Patients with perceived high-bleeding risk and computerized decision support for stroke prevention in atrial fibrillation: an AF-ALERT substudy Gregory PiazzaShelley HurwitzSamuel Z. Goldhaber OriginalPaper 30 September 2020 Pages: 281 - 290
Bridge mechanical thrombectomy may be a better choice for acute large vessel occlusions Mingming ZhaKangmo HuangXinfeng Liu OriginalPaper 20 October 2020 Pages: 291 - 300
Clopidogrel increases risk of pneumonia compared with aspirin in acute ischemic minor stroke patients Zhangfeng YuHua ZhouXing Jin OriginalPaper 09 October 2020 Pages: 301 - 307
The experience of Hamad General Hospital collaborative anticoagulation clinic in Qatar during the COVID-19 pandemic Ibtihal AbdallahAsma EltahirAbdel-nasser Elzouki OriginalPaper Open access 04 October 2020 Pages: 308 - 314
Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants Niklas WallvikHenrik RenlundAnders Själander OriginalPaper Open access 02 November 2020 Pages: 315 - 323
FVII gene R353Q polymorphism and coronary heart disease: a meta-analysis including 3258 subjects Yan-yan LiHui WangYang-yang Zhang OriginalPaper 02 January 2021 Pages: 324 - 330
Incidence and risk factors for PTT prolongation in patients receiving low-dose unfractionated heparin thromboprophylaxis David FeinbloomJason A. FreedShoshana J. Herzig OriginalPaper 02 October 2020 Pages: 331 - 337
Massive intraperitoneal hemorrhage in patients with COVID-19: a case series Vahid Reisi-VananiZahra LorigooiniFereidoun Rahmani Report 28 April 2021 Pages: 338 - 344
Bivalirudin dosing during prolonged intermittent renal replacement therapy: a case report Nicole M. BohmChase Brown BriefCommunication 17 October 2020 Pages: 345 - 349
Internuclear ophthalmoplegia as an atypical presentation of lacunar stroke in CADASIL Carlos FigueiredoMariana FernandesCristina Costa BriefCommunication 02 January 2021 Pages: 350 - 353
Highlights from the American society of hematology conference 2020 Punita GroverShuchi Gulati ReviewPaper 26 April 2021 Pages: 354 - 362